Feds look to OTC drugs for self-treatment of mild, moderate COVID
By
Alicia Lasek
Apr 21, 2021
A large trial is set to study the potential for repurposed, over-the-counter drugs to treat mild-to-moderate COVID-19 symptoms. If found effective, the approval timeline will likely be short, according...
NIH releases COVID-19 treatment guidelines, warns against drug combo
By
Alicia Lasek
Apr 22, 2020
The comprehensive guidelines are posted in a “living document” that will be updated as new information and evidence emerges, the agency announced Tuesday.
New NIH network to recruit thousands for late-stage COVID-19 vaccine trials
By
Alicia Lasek
Jul 09, 2020
A nationwide clinical trial network will test promising COVID-19 vaccines and antibodies. There are five possible vaccine candidates.
Fauci: ‘Pan-viral’ vaccine may be needed to tackle tenacious COVID-19 long-term
By
Alicia Lasek
Feb 16, 2021
The virus that causes COVID-19 likely is here to stay, and its success in humans means that stronger defense measures will be needed, say Anthony Fauci, M.D., and colleagues from the National Institute...
Feds identify promising and ‘urgently needed’ COVID antiviral drug
By
Alicia Lasek
Jun 04, 2021
The experimental drug TEMPOL has shown promise in early studies, halting the activity of a viral enzyme and limiting the severity of SARS-CoV-2 infections.
Remdesivir effective against COVID-19, researchers conclude
By
Alicia Lasek
Oct 13, 2020
Intravenous remdesivir shortens recovery time and reduces mortality in hospitalized patients when compared to placebo, according to final trial data from NIAID. No other antiviral has yet been confirmed...